Related Experiment Videos
Drug interactions in surgical patients.
American Journal of Surgery
|March 1, 1987
Summary
Drug interactions in surgical patients can cause harm and prolong hospital stays. Recognizing and managing these interactions, often involving pharmacokinetic or pharmacodynamic changes, is crucial for patient safety.
Area of Science:
- Pharmacology
- Clinical Medicine
- Patient Safety
Background:
- Drug interactions are common in surgical patients, potentially leading to increased morbidity and extended hospital stays.
- These interactions can manifest as drug ineffectiveness or exaggerated pharmacologic responses.
- Most drug interactions involve altered pharmacokinetics (absorption, distribution, metabolism, elimination) or pharmacodynamics (synergistic, additive, antagonistic effects).
Purpose of the Study:
- To highlight the frequency and clinical significance of drug interactions in surgical patients.
- To emphasize the importance of recognizing potential adverse drug interactions.
- To discuss strategies for minimizing the effects of drug interactions.
Main Methods:
- Review of existing literature on drug interactions in surgical settings.
- Identification of common drug classes involved in interactions (e.g., histamine-2 blockers, digoxin, warfarin).
- Discussion of pharmacokinetic and pharmacodynamic mechanisms underlying drug interactions.
Main Results:
- Drug interactions are a significant concern in surgical patient care.
- Commonly implicated drugs include histamine-2 blockers (e.g., cimetidine), digoxin, and warfarin.
- Multiple drug interactions in patients on polypharmacy present complex, unpredictable effects.
Conclusions:
- Proactive recognition of potential drug interactions is essential for minimizing adverse events.
- Concurrent administration of interacting drugs requires careful patient and laboratory monitoring.
- Therapeutic drug monitoring, such as serum concentration measurements for digoxin or theophylline, can aid in preventing adverse outcomes.